20 December 2021 - From 1 January 2022, tens of thousands of Australians with symptomatic heart failure will have access to ...
17 December 2021 - Prostate Cancer Foundation of Australia has welcomed recommendations by Australia’s Pharmaceutical Benefits Advisory Committee to list ...
17 December 2021 - The recommendations from the November 2021 PBAC meeting are now available. ...
10 December 2021 - The summary of price disclosure price reductions for the 2022 April Cycle has now been published ...
7 December 2021 - A biosimilar brand of follitropin alfa (Ovaleap) was listed on the PBS on 1 December 2021. ...
5 December 2021 - We review the new medicines listed on the PBS in 2021. ...
3 December 2021 - The agenda for the December 2021 PBAC intracycle meeting is now available. ...
2 December 2021 - Australians will see improved access to new and innovative medicines, vaccines and treatments as a landmark ...
2 December 2021 - Version 3 came and went quickly; the current version (version 4) makes no reference to the ...
1 December 2021 - The December 2021 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
28 November 2021 - From 1 December 2021, Australians with acute myeloid leukaemia will have access to a new treatment option ...
26 November 2021 - The agenda for the March 2022 PBAC agenda has been revised within 48 hours of publication. ...
26 November 2021 - More insights from the MAESTrO Team. ...
26 November 2021 - Some insights from the MAESTrO Team. ...
25 November 2021 - A new parliamentary report ‘The New Frontier: Delivering better health for all Australians’ is recommending significant ...